Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marr Technologies Asia is a medical device company specializing in the development and commercialization of innovative surgical tools, with a primary focus on male circumcision. The company's lead product, the CircumC device, is a sterile, single-use instrument designed to provide a safe, rapid, and standardized method for performing circumcisions in both infants and adults. By simplifying the surgical process, Marr Technologies Asia aims to improve clinical outcomes and support large-scale public health initiatives, particularly those focused on HIV prevention in high-burden regions. The company operates as a key supplier for global health organizations and healthcare providers, emphasizing cost-effectiveness and procedural safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marr Technologies Asia.